Clinical Trials Browser

Terminated × BO-112 × Clear all

NCT04508140 2024-11-29

Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis

Phase 2 Terminated

18 enrolled 13 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04777708 2023-03-24

BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular